ClinicalTrials.Veeva

Menu

Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer Patients

M

Mahidol University

Status

Terminated

Conditions

Corneal Ulcer

Treatments

Procedure: NSS/Lidocaine
Procedure: Lidocaine/NSS

Study type

Interventional

Funder types

Other

Identifiers

NCT00789646
SI 271/2008

Details and patient eligibility

About

The propose of this study is to determine the efficacy of 2% xylocaine in reducing pain due to subconjunctival antibiotic and antifungal injection.

Enrollment

10 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The corneal ulcer patients who are diagnosed by ophthalmologist and have 2 of 3 in these following features.

    1. corneal epithelial defect with stromal infiltration
    2. reaction in anterior chamber
    3. positive for bacteria or fungus
  • The patients have to receive subconjunctival antibiotic injection twice at least.

  • The patients must be informed consent.

Exclusion criteria

  • The patients who have history of allergy of local anesthetics, antibiotics or antifungal drugs.
  • The patients who administered NSAIDs or weak opioids within 24 hours prior to subconjunctival antibiotic/antifungal injection.
  • Unable to cooperate with the treatment.
  • Pregnant women

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

10 participants in 2 patient groups

NSS/Lidocaine
Experimental group
Description:
First injection: Normal saline Second injection: 2% Lidocaine without adrenaline
Treatment:
Procedure: NSS/Lidocaine
Lidocaine/NSS
Experimental group
Description:
First injection: 2% Lidocaine without adrenaline Second injection: Normal saline
Treatment:
Procedure: Lidocaine/NSS

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems